About
OncoGenesys is a next-generation biotech company dedicated to transforming cancer treatment by harnessing the power of the adaptive immune system. We specialize in uncovering and targeting the mechanisms that govern anti-tumor immunity — with the ultimate goal of designing precision immunotherapies.
In addition to our internal R&D pipeline, OncoGenesys also offers specialized services in bulk, single-cell and spatial omics biomedical data analysis, as well as in vitro and in vivo cancer models for preclinical drug evaluation. These services can be provided end-to-end — from experimental design and data acquisition to processing and analysis using AI algorithms and biological interpretation — and are tailored to the specific needs of each project through direct consultation.
OncoGenesys stands at the intersection of immunology, data science, and drug discovery — advancing a new era of personalized and immune-guided cancer therapies.
Our
Story
OncoGenesys was born from a lifelong passion to understand the fundamental principles of biological systems and to translate that knowledge into better outcomes for patients.
Our founder began her journey in medicine, dedicating 15 years as a respiratory physician treating patients with complex lung diseases, including cancer. Alongside her clinical work, she pursued translational research with unwavering determination—seeking to decode the immune principles of tissue organization in respiratory disorders.
A decade ago, she fully devoted herself to research, gathering a team of like-minded scientists who shared her vision. Her pioneering studies revealed that tumor tissues are not passive, but rather “self-organized immune environments” capable of sustaining antigen-specific immune responses against cancer—independently of lymph nodes. Building on this foundation, she set out to bridge the gap between discovery and therapy.
In 2025, she founded OncoGenesys, with the mission to give “genesis” to innovative solutions for cancer patients. At the heart of OncoGenesys lies her conviction that only through deep biological knowledge and cutting-edge scientific tools can we develop the next generation of cancer treatments.
OncoGenesys exists to connect science and medicine, mechanisms and treatments, and to bring forth therapies that will transform cancer care.